COMMUNIQUÉS West-GlobeNewswire

Solo Growth Corp™ Announces Operational Update and First Quarter 2019 Results
23/05/2019
CALGARY, Alberta, May 23, 2019 (GLOBE NEWSWIRE) -- Solo Growth Corp.™ (the “ Company ” or “ Solo Growth ”) (TSXV: SOLO) (WKN:A2PBMC), a cannabis retailer operating as YSS TM with the vision to become a premier retailer [...]
Brainsway Ltd. to Host First Quarter 2019 Financial Results Conference Call on May 29, 2019
23/05/2019
JERUSALEM and HACKENSACK, N.J., May 23, 2019 (GLOBE NEWSWIRE) -- Brainsway Ltd. (NASDAQ & TASE: BWAY) (“Brainsway”), a commercial stage medical device company focused on the development and sale of non-invasive [...]
Dentsply Sirona Board Approves Relocation of Headquarters to Charlotte N.C. and Announces CFO Transition Plan
23/05/2019
CHARLOTTE, N.C., May 23, 2019 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental Solutions Company, today announced that the Board of Directors approved the relocation of the Company [...]
Medcolcanna Announces Commencement of Trading on the TSX Venture Exchange Under the Symbol MCCN and Other Corporate Matters
23/05/2019
Medcolcanna to Acquire Innovative CBD Products B.V. as Part of Continued Strategic Initiatives BOGOTÁ, Colombia, May 23, 2019 (GLOBE NEWSWIRE) -- Medcolcanna Organics Inc . (TSX-V: MCCN) (“ Medcolcanna ” or the “ [...]
So-Young to Report First Quarter 2019 Financial Results on May 30, 2019
23/05/2019
BEIJING, May 23, 2019 (GLOBE NEWSWIRE) -- So-Young International Inc. (NASDAQ: SY) (“So-Young” or the “Company”), the most popular online destination for discovering, evaluating and reserving medical aesthetic services [...]
Mesoblast Keynote Presentations to Feature at 2019 Annual Meeting of the International Society for Cell and Gene Therapy
23/05/2019
MELBOURNE, Australia; and NEW YORK, May 23, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in cellular medicines for inflammatory diseases, will feature at the International Society for [...]
PCI Biotech: First patient enrolled in the fimaChem pivotal RELEASE study
23/05/2019
Oslo (Norway), 23 May 2019 – PCI Biotech (OSE: PCIB), a cancer focused clinical-stage company developing innovative therapeutics that address significant unmet medical needs today announced first patient enrolled in the [...]
Curetis Reports Positive Results from Clinical Validation Study for U.S. FDA 510(k) Submission of Unyvero LRT for BAL Samples
23/05/2019
- Test shows overall weighted average sensitivity of 90.1% (94.7%) and overall weighted average specificity of 98.4% (97.9%) in prospective (retrospective) sample cohort - U.S. FDA 510(k) submission for Unyvero LRT BAL [...]
NÉOVACS PROCÈDE AUX TIRAGES DE LA SECONDE TRANCHE PRÉVUE PAR SON PROGRAMME DE FINANCEMENT ET D’UNE TRANCHE ADDITIONNELLE POUR UN MONTANT TOTAL DE 3,3 MILLIONS D’EUROS
23/05/2019
COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE NÉOVACS PROCÈDE AUX TIRAGES DE LA SECONDE TRANCHE PRÉVUE PAR SON PROGRAMME DE FINANCEMENT ET D’UNE TRANCHE ADDITIONNELLE POUR UN MONTANT TOTAL DE 3,3 [...]
Novartis highlights company transformation, catalyst-rich pipeline, and strong progress on strategy at Meet Novartis Management investor event
23/05/2019
Driving growth through cutting edge pipeline with 15 in-market blockbusters and more than 25 potential blockbusters in development, including 10+ planned launches by 2021 Strong progress on productivity efforts to [...]
Santhera Enters into License Agreement with Chiesi Group for Raxone® in LHON Valued at up to CHF 105 Million
23/05/2019
Transaction allows Santhera to advance its long-term growth strategy by focusing on the development of its clinical-stage neuromuscular and pulmonary programs Deal includes upfront cash payment of CHF 50 million (EUR 44 [...]
Novadip Biosciences presents data at 30th annual EURAPS Research Council Meeting
23/05/2019
Novadip Biosciences presents data at 30 th annual EURAPS Research Council Meeting Data demonstrates safety and efficacy of allogenic 3D scaffold-free tissue engineered product for deep thickness skin regeneration Mont- [...]
INNATE PHARMA ANNOUNCES PUBLICATION ON NEXT GENERATION IMMUNOTHERAPIES TARGETING THE ADENOSINE PATHWAY IN “CELL REPORTS”
23/05/2019
The production of adenosine via CD39 and CD73 enzymes participates in an immunosuppressive tumor microenvironment. Perrot et al. generated two antibodies, IPH5201 and IPH5301, targeting human CD39 and CD73, respectively [...]
Innate Pharma annonce une publication dans “Cell Reports” sur une nouvelle génération d'immunothérapies ciblant la voie adénosine
23/05/2019
La production d'adénosine via les enzymes CD39 et CD73 participe à l’immunosuppression dans le microenvironnement tumoral. Les auteurs Perrot et al., ont produit deux anticorps, IPH5201 et IPH5301, ciblant [...]
Outcome of Annual General Meeting of May 22, 2019
23/05/2019
Marseille, France, May 23, 2019, 7:00 AM CEST Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces the results of the voting by shareholders at the Annual General Meeting (“AGM”) which took place on May 22, 2019 [...]
Résultats de l’Assemblée générale mixte du 22 mai 2019
23/05/2019
Marseille, le 23 mai 2019, 7h00 CEST Innate Pharma SA (Euronext Paris : FR0010331421 – IPH) annonce les résultats du vote des actionnaires à l’Assemblée générale mixte qui s’est tenue à Marseille le 22 mai 2019. Toutes [...]
Guardant Health Announces Pricing of Public Offering of Common Stock
23/05/2019
REDWOOD CITY, Calif., May 22, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq:GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast [...]
Arch Biopartners Closes Convertible Note Financing
22/05/2019
TORONTO, May 22, 2019 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced it has closed the non-brokered, unsecured convertible note (“Note”) financing it [...]
Dentsply Sirona Declares Quarterly Cash Dividend
22/05/2019
CHARLOTTE, N.C., May 22, 2019 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY), The Dental Solutions Company™, announced that its Board of Directors declared a quarterly cash dividend of $0. [...]

Pages